4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for 4D Molecular Therapeutics stock ranges from a low of $6.00 to a high of $40. The average analyst price target of $30.33 forecasts a 183.46% increase in the stock price over the next year.

Price Target: $30.33 (+183.46%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$30.33	$33	$40
Change	-43.93%	+183.46%	+208.41%	+273.83%

Analyst Ratings

The average analyst rating for 4D Molecular Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	4	4	4	4	4
Buy	4	3	3	4	4	4
Hold	1	1	1	0	0	0
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	10	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Lisa Walter RBC Capital	RBC Capital	Buy Maintains $26 → $32	Buy	Maintains	$26 → $32	+199.07%	Nov 11, 2025
Gena Wang Barclays	Barclays	Buy Maintains $38 → $33	Buy	Maintains	$38 → $33	+208.41%	Nov 11, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $25 → $26	Strong Buy	Maintains	$25 → $26	+142.99%	Nov 11, 2025
Lisa Walter RBC Capital	RBC Capital	Buy Reiterates $26	Buy	Reiterates	$26	+142.99%	Oct 21, 2025
Salveen Richter Roth Capital	Roth Capital	Strong Buy Maintains $44 → $38	Strong Buy	Maintains	$44 → $38	+255.14%	Aug 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

7.87M

Increased by 21,181.08%

from 37.00K

Revenue Next Year

20.66M

Increased by 162.43%

from 7.87M

EPS This Year

-3.75

from -2.98

EPS Next Year

-3.55

from -3.75

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	13.61M	18.04M	3.13M	20.72M	37.00K	7.87M	20.66M
Revenue Growth	94.85%	32.52%	-82.65%	562.29%	-99.82%	21,181.08%	162.43%
EPS	-8.82	-2.57	-3.32	-2.58	-2.98	-3.75	-3.55
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	19.0M	53.9M
Avg	7.9M	20.7M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	51,264.9%	584.1%
Avg	21,181.1%	162.4%
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-3.47	-2.73
Avg	-3.75	-3.55
Low	-3.82	-4.21

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.